CTA
ATRA icon

Carillon Tower Advisers’s Atara Biotherapeutics ATRA Stock Holding History

Carillon Tower Advisers’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-48,810
Closed -$9.49M – 463
2020
Q1 		$9.49M Hold
48,810
– – 0.09% 278
2019
Q4 		$20.1M Hold
48,810
– – 0.13% 254
2019
Q3 		$17.2M Hold
48,810
– – 0.12% 267
2019
Q2 		$24.5M Hold
48,810
– – 0.17% 218
2019
Q1 		$48.5M Sell
48,810
-2,648
-5% -$2.46M 0.34% 100
2018
Q4 		$44.7M Hold
51,458
– – 0.38% 80
2018
Q3 		$53.2M Hold
51,458
– – 0.38% 83
2018
Q2 		$47.3M Hold
51,458
– – 0.37% 87
2018
Q1 		$47.5M Hold
51,458
– – 0.37% 82
2017
Q4 		$23.3K Buy
+51,458
New +$19M 0.25% 161

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return